MARC Record from Library of Congress

LEADER: 02335nam a2200325 a 4500
001 98186785
003 DLC
005 19981209084425.0
008 980821s1998 mdua b f000 0 eng d
010 $a 98186785
035 $a(OCoLC)39743478
040 $aMoU$cMoU$dMnSSC$dDLC
042 $alccopycat
043 $an-us---
050 00 $aHV5825$b.C665 1998
245 00 $aCost-benefit/cost-effectiveness research of drug abuse prevention :$bimplications for programming and policy /$ceditors, William J. Bukoski, Richard I. Evans.
260 $aRockville, MD :$bU.S. Dept. of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse, Division of Epidemiology and Prevention Research,$c1998.
300 $aiv, 233 p. :$bill. ;$c24 cm.
440 0 $aNIDA research monograph ;$v176
440 0 $aNIH publication ;$vno. 98-4021
500 $a"Based on the papers from a technical review ... held on July 28-29, 1994"--P. ii.
504 $aIncludes bibliographical references.
505 0 $aImpact of substance abuse on federal spending -- Historical perspective on effective prevention -- School-based approaches to drug abuse prevention: evidence for effectiveness and suggestions for determining cost-effectiveness -- Effectiveness of prevention interventions with youth at high risk of drug abuse -- Costs, benefits, and cost-effectiveness of comprehensive drug abuse prevention -- Overview of methods: cost-effectiveness, cost-benefits, and cost-offsets of prevention -- Analytic issues for estimating the benefits and costs of substance abuse prevention -- Benefits and costs of a family-focused methadone treatment and drug abuse prevention program: preliminary findings -- Issues and methods in evaluating costs, benefits, and cost-effectiveness of drug abuse prevention programs for high-risk youth -- Implications for prevention policy: a commentary.
650 0 $aDrug abuse$zUnited States$xPrevention$xFinance.
650 12 $aSubstance-Related Disorders$xprevention & control$zUnited States.
650 22 $aSubstance-Related Disorders$xeconomics$zUnited States.
650 22 $aCost-Benefit Analysis.
700 1 $aBukoski, William J.
700 1 $aEvans, Richard I.$q(Richard Isadore),$d1922-
710 2 $aNational Institute on Drug Abuse.$bDivision of Epidemiology and Prevention Research.